CGON vs LGND
Comparison between Cg Oncology Inc (CGON, Company) and Ligand Pharmaceuticals Inc - Class B (LGND, Company).
Both CGON and LGND are from the Healthcare sector.
CGON vs LGND - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
CGON
$6.10B
LGND
$6.09B
Max Drawdown
Winner
CGON
67.47%
LGND
95.01%
Sharpe Ratio
CGON
1.90
Winner
LGND
2.26
5Y Beta
CGON
1.46
Winner
LGND
0.98
Industry
CGON
Biotechnology
LGND
Biotechnology
P/E Ratio
Winner
CGON
-30.15
LGND
38.94
Forward P/E
CGON
N/A
LGND
33.90
PEG Ratio
Winner
CGON
-0.52
LGND
1.53
5Y EPS CAGR
CGON
N/A
LGND
26.59%
Debt to Equity
CGON
0.27%
Winner
LGND
0.00%
Free Cash Flow Yield
CGON
-2.63%
Winner
LGND
2.02%
P/S Ratio
CGON
1205.54
Winner
LGND
22.22
P/B Ratio
Winner
CGON
5.80
LGND
6.13
CGON vs LGND - Historical Returns
Returns include dividend reinvestment.
1M
CGON
+0.87%
Winner
LGND
+5.48%
3M
CGON
+0.93%
Winner
LGND
+29.95%
6M
CGON
+28.82%
Winner
LGND
+49.41%
1Y
Winner
CGON
+165.19%
LGND
+126.25%
5Y(CAGR)
CGON
N/A
LGND
+19.75%
10Y(CAGR)
CGON
N/A
LGND
+8.45%
Max(CAGR)
Winner
CGON
+28.39%
LGND
+8.26%
CGON vs LGND - Annual Returns (1999 - 2026)
Returns include dividend reinvestment.
| Year | CGON | LGND |
|---|---|---|
| 2026 | +65.88% | +58.08% |
| 2025 | +43.32% | +74.39% |
| 2024 | -22.84% | +48.18% |
| 2023 | N/A | +8.16% |
| 2022 | N/A | -55.93% |
| 2021 | N/A | +52.82% |
| 2020 | N/A | -5.05% |
| 2019 | N/A | -23.88% |
| 2018 | N/A | -2.11% |
| 2017 | N/A | +33.59% |
| 2016 | N/A | -0.84% |
| 2015 | N/A | +101.79% |
| 2014 | N/A | +3.28% |
| 2013 | N/A | +153.86% |
| 2012 | N/A | +74.14% |
| 2011 | N/A | +32.04% |
| 2010 | N/A | -27.63% |
| 2009 | N/A | -19.63% |
| 2008 | N/A | -43.62% |
| 2007 | N/A | -41.09% |
| 2006 | N/A | -4.78% |
| 2005 | N/A | -0.45% |
| 2004 | N/A | -22.04% |
| 2003 | N/A | +168.56% |
| 2002 | N/A | -68.50% |
| 2001 | N/A | +30.18% |
| 2000 | N/A | +0.86% |
| 1999 | N/A | +52.61% |
CGON vs LGND Drawdown Comparison
The maximum drawdown for CGON was -67.47%, occurring on Apr 8, 2025. Recovery took 475 trading sessions.
The maximum drawdown for LGND was -93.36%, occurring on Nov 19, 2008. Recovery took 3876 trading sessions.
The current CGON drawdown is -7.87%. The current LGND drawdown is -6.84%.
| Rank | CGON | LGND |
|---|---|---|
| #1 | -67.47% Feb 16, 2024 - Jan 9, 2026 | -93.36% Mar 6, 2000 - Aug 3, 2015 |
| #2 | -27.41% May 13, 2026 - Jul 10, 2026 | -81.94% Sep 28, 2018 - Jun 18, 2026 |
| #3 | -13.88% Jan 21, 2026 - Feb 20, 2026 | -34.19% Aug 1, 2016 - Oct 4, 2017 |
| #4 | -11.82% Apr 17, 2026 - May 13, 2026 | -26.20% Aug 5, 2015 - Dec 16, 2015 |
| #5 | -7.88% Jul 10, 2026 - Jul 22, 2026 | -23.30% Dec 17, 2015 - Apr 6, 2016 |
| #6 | -6.99% Mar 17, 2026 - Apr 7, 2026 | -17.44% Mar 12, 2018 - May 15, 2018 |
| #7 | -5.76% Jan 25, 2024 - Jan 31, 2024 | -16.85% Dec 10, 1999 - Dec 29, 1999 |
| #8 | -5.64% Feb 1, 2024 - Feb 7, 2024 | -16.72% Jan 24, 2000 - Feb 10, 2000 |
| #9 | -4.97% Apr 7, 2026 - Apr 17, 2026 | -14.25% Apr 21, 2016 - Jul 20, 2016 |
| #10 | -4.40% Jan 14, 2026 - Jan 21, 2026 | -14.12% Feb 18, 2000 - Mar 6, 2000 |
| #11 | -3.82% Feb 24, 2026 - Feb 27, 2026 | -12.70% Nov 8, 2017 - Jan 11, 2018 |
| #12 | -3.70% Feb 7, 2024 - Feb 9, 2024 | -10.80% Jan 29, 2018 - Mar 8, 2018 |
| #13 | -2.99% Jan 9, 2026 - Jan 14, 2026 | -9.76% Nov 15, 1999 - Nov 29, 1999 |
| #14 | -2.61% Mar 11, 2026 - Mar 16, 2026 | -8.87% Jul 9, 2026 - Jul 20, 2026 |
| #15 | -1.95% Mar 4, 2026 - Mar 6, 2026 | -7.39% Jul 26, 2018 - Aug 7, 2018 |
Correlation
Correlation between CGON and LGND is 0.78 which considered as a strong positive correlation - the stocks tend to move together.
0.78
-101
Select Stocks to Compare
Popular: CGON vs SPYLGND vs SPY
More Comparisons
Compare with similar stocks